Leukemia, Prolymphocytic - 55 Studies Found
Completed |
: Combined Immunochemotherapy in Patients With T-Prolymphocytic Leukemia (T-PLL) : T-cell-prolymphocytic Leukemia : 2010-08-20 :
|
Terminated |
: Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients With Prolymphocytic Leukemia : Prolymphocytic Leukemia : 2006-01-24 :
|
Completed |
: Combination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia : Prolymphocytic Leukemia : 2006-01-16 :
|
Terminated |
: Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia :
: Drug: alvocidib Other Names: |
Active, not recruiting |
: PCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic Leukemia :
|
Completed |
: Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL) :
|
Terminated |
: Alvespimycin Hydrochloride in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia :
: |
Terminated |
: A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Participants With Chronic Leukemia :
|
Terminated |
: 17-N-Allylamino-17-Demethoxygeldanamycin With or Without Rituximab in Treating Patients With Relapsed B-Cell Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia :
: |
Withdrawn |
: Phase II Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic Leukemia :
: 2010-07-12 : Drug: Velcade IV Other Name: Bortezomib |